Tadalafil Tablet
Product Images NDC 68071-3753

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 68071-3753). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3753 3)

FDA Label Image

F35596a7-figure-01 (F35596a7 Figure 01)

FDA Label Image

F35596a7-figure-02 (F35596a7 Figure 02)

FDA Label Image

F35596a7-figure-03 (F35596a7 Figure 03)

F35596a7-figure-03 (F35596a7 Figure 03)
This text provides information regarding the standing systolic blood pressure (BP) in mmHg for a specific dosing regimen of Tadalafil (20 mg) and Doxazosin (8 mg). It may be a reference to monitor the effects of these medications on blood pressure levels.*
FDA Label Image

F35596a7-figure-04 (F35596a7 Figure 04)

FDA Label Image

F35596a7-figure-05 (F35596a7 Figure 05)

FDA Label Image

F35596a7-figure-06 (F35596a7 Figure 06)

F35596a7-figure-06 (F35596a7 Figure 06)
The text provides information on the change in IPSS Total Score over the duration of treatment (in weeks) with Tadalafil tablets 5 mg compared to placebo. The data indicates a statistically significant difference between the two groups (*p<0.01).*
FDA Label Image

F35596a7-figure-07 (F35596a7 Figure 07)

F35596a7-figure-07 (F35596a7 Figure 07)
This text provides information related to a study that includes Tadalafil tablets of 5 mg dosage, a placebo, and statistical significance denoted by the term "p<0.001". The chart also includes a duration of treatment in weeks ranging from 0 to 12.*
FDA Label Image

F35596a7-figure-08 (F35596a7 Figure 08)

FDA Label Image

F35596a7-figure-09 (F35596a7 Figure 09)

F35596a7-figure-09 (F35596a7 Figure 09)
This text seems to provide information related to a study or experiment involving Tadalafil tablets at 5 mg compared to a placebo. The results indicate a statistically significant difference with a p-value less than 0.01. The graph illustrates the duration of treatment in weeks along with the corresponding effects observed.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.